KR900008441B1 - 옥시캄 유도체를 함유하는 제약조성물의 제조방법 - Google Patents

옥시캄 유도체를 함유하는 제약조성물의 제조방법 Download PDF

Info

Publication number
KR900008441B1
KR900008441B1 KR1019830001935A KR830001935A KR900008441B1 KR 900008441 B1 KR900008441 B1 KR 900008441B1 KR 1019830001935 A KR1019830001935 A KR 1019830001935A KR 830001935 A KR830001935 A KR 830001935A KR 900008441 B1 KR900008441 B1 KR 900008441B1
Authority
KR
South Korea
Prior art keywords
oxycam
methyl
general formula
derivative
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019830001935A
Other languages
English (en)
Korean (ko)
Other versions
KR840004509A (ko
Inventor
게브 하르트 우베
아우가르트 헬뮤트
크네흐트 아돌프
Original Assignee
괴데케 악티엔게젤샤프트
테하 슈베르트, 이 만스만
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 괴데케 악티엔게젤샤프트, 테하 슈베르트, 이 만스만 filed Critical 괴데케 악티엔게젤샤프트
Publication of KR840004509A publication Critical patent/KR840004509A/ko
Application granted granted Critical
Publication of KR900008441B1 publication Critical patent/KR900008441B1/ko
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1019830001935A 1982-05-08 1983-05-06 옥시캄 유도체를 함유하는 제약조성물의 제조방법 Expired KR900008441B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3217315 1982-05-08
DE3217315A DE3217315C2 (de) 1982-05-08 1982-05-08 Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten

Publications (2)

Publication Number Publication Date
KR840004509A KR840004509A (ko) 1984-10-22
KR900008441B1 true KR900008441B1 (ko) 1990-11-22

Family

ID=6163066

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830001935A Expired KR900008441B1 (ko) 1982-05-08 1983-05-06 옥시캄 유도체를 함유하는 제약조성물의 제조방법

Country Status (23)

Country Link
US (1) US4482554A (cg-RX-API-DMAC7.html)
EP (1) EP0093999B1 (cg-RX-API-DMAC7.html)
JP (1) JPS5931713A (cg-RX-API-DMAC7.html)
KR (1) KR900008441B1 (cg-RX-API-DMAC7.html)
AR (1) AR230634A1 (cg-RX-API-DMAC7.html)
AT (1) ATE29383T1 (cg-RX-API-DMAC7.html)
AU (1) AU551337B2 (cg-RX-API-DMAC7.html)
CA (1) CA1204668A (cg-RX-API-DMAC7.html)
DD (1) DD211484A5 (cg-RX-API-DMAC7.html)
DE (2) DE3217315C2 (cg-RX-API-DMAC7.html)
DK (1) DK157731C (cg-RX-API-DMAC7.html)
ES (1) ES8405274A1 (cg-RX-API-DMAC7.html)
FI (1) FI79944C (cg-RX-API-DMAC7.html)
GR (1) GR77503B (cg-RX-API-DMAC7.html)
HU (1) HU197208B (cg-RX-API-DMAC7.html)
IE (1) IE54729B1 (cg-RX-API-DMAC7.html)
IL (1) IL68421A (cg-RX-API-DMAC7.html)
NO (1) NO163314C (cg-RX-API-DMAC7.html)
NZ (1) NZ204086A (cg-RX-API-DMAC7.html)
PH (2) PH22726A (cg-RX-API-DMAC7.html)
SU (1) SU1295993A3 (cg-RX-API-DMAC7.html)
YU (1) YU90383A (cg-RX-API-DMAC7.html)
ZA (1) ZA832816B (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346526C2 (de) * 1983-12-22 1986-12-11 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutisches Präparat zur therapeutischen Behandlung von rheumatischen Erkrankungen
DE3435843A1 (de) * 1984-09-29 1986-04-03 Gödecke AG, 1000 Berlin Antirheumatisch wirksame suppositorien
DE3437232A1 (de) * 1984-10-10 1986-04-17 Mack Chem Pharm Stabilisierte injektionsloesungen von piroxicam
JPH0430634Y2 (cg-RX-API-DMAC7.html) * 1985-06-10 1992-07-23
IT1207994B (it) * 1986-01-03 1989-06-01 Therapicon Srl Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
ES2038733T3 (es) * 1987-12-04 1993-08-01 Asta Medica Ag Procedimiento para preparar una solucion inyectable de la sal de acido tioctico con trometanol y/o aminoacidos basicos.
HU205550B (en) * 1990-11-27 1992-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pyroxycam solution of increased stability, free from effects damaging tussues
EP0560900B1 (en) * 1990-12-03 1995-02-08 Vestar, Inc. Prevention of synovial adhesions
IT1283252B1 (it) * 1996-03-15 1998-04-16 Pulitzer Italiana Soluzioni di piroxicam iniettabili per via parenterale
WO1999041233A1 (en) * 1998-02-17 1999-08-19 Micio Pharma Chemical Aktiengesellschaft A watersoluble nimesulide adduct also for injectable use
US6369328B1 (en) 1998-03-14 2002-04-09 The Furukawa Electric Co., Ltd. Heat dissipating device for transmission line, transmission line with heat dissipating device, and method for fitting heat dissipating device to transmission line
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
SG166115A1 (en) * 2005-09-30 2010-11-29 Boehringer Ingelheim Vetmed Pharmaceutical preparation containing meloxicam
US9101529B2 (en) 2009-10-12 2015-08-11 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
WO2011107150A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629650A (cg-RX-API-DMAC7.html) * 1967-05-18 1900-01-01
SE421792B (sv) * 1976-01-12 1982-02-01 Pfizer Forfarande for framstellning av n-(2-pyridyl)-4-hydroxi-2-metyl-2h-1,2-benso-tiazin-3-karboxamid-1,1-dioxid
DE2756113A1 (de) * 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
JPH0257049B2 (cg-RX-API-DMAC7.html) 1990-12-03
PH24334A (en) 1990-05-29
FI79944C (fi) 1990-04-10
IE830785L (en) 1983-11-08
IL68421A0 (en) 1983-07-31
SU1295993A3 (ru) 1987-03-07
DK204683A (da) 1983-11-09
EP0093999A2 (de) 1983-11-16
PH22726A (en) 1988-11-28
NO831610L (no) 1983-11-09
NO163314C (no) 1990-05-09
DK157731C (da) 1990-07-16
FI831534L (fi) 1983-11-09
EP0093999B1 (de) 1987-09-09
NO163314B (no) 1990-01-29
DE3373414D1 (en) 1987-10-15
DE3217315A1 (de) 1983-11-10
ATE29383T1 (de) 1987-09-15
AU551337B2 (en) 1986-04-24
ES522107A0 (es) 1984-06-01
ES8405274A1 (es) 1984-06-01
IL68421A (en) 1986-04-29
IE54729B1 (en) 1990-01-17
DK157731B (da) 1990-02-12
DD211484A5 (de) 1984-07-18
NZ204086A (en) 1986-02-21
DK204683D0 (da) 1983-05-06
US4482554A (en) 1984-11-13
AU1366483A (en) 1983-11-10
CA1204668A (en) 1986-05-20
GR77503B (cg-RX-API-DMAC7.html) 1984-09-24
JPS5931713A (ja) 1984-02-20
EP0093999A3 (en) 1985-05-15
FI79944B (fi) 1989-12-29
DE3217315C2 (de) 1986-05-22
FI831534A0 (fi) 1983-05-04
KR840004509A (ko) 1984-10-22
YU90383A (en) 1988-02-29
AR230634A1 (es) 1984-05-31
ZA832816B (en) 1983-12-28
HU197208B (en) 1989-03-28

Similar Documents

Publication Publication Date Title
US4482554A (en) Pharmaceutical compositions containing oxicam derivatives and process for their preparation
CA1234050A (en) Injectable solution for the treatment of inflammations
RU2085191C1 (ru) Жидкая антибактериальная композиция
FI84315C (fi) Foerfarande foer framstaellning av en stabil, vattenhaltig, injekterbar piroxikamloesning.
US4794117A (en) Process for solubilizing active ingredients and the thus-obtained pharmaceutical compositions
JPS59206305A (ja) ニモジピンの非経口投与組成物
RU2062616C1 (ru) Жидкая лекформа пироксикама
FI78837C (fi) Foerfarande foer framstaellning av en foer injektionsadministration laemplig, stabil och saltsyrahaltig vattenloesning av cis-platina.
FI119970B (fi) Enrofloksasiini-injektio- tai infuusioliuoksia
KR101202649B1 (ko) 소듐 디클로페낙 및 β-시클로덱스트린을 포함하는 주사용약학 조성물
US2857312A (en) Esters of erythromycin and carbomycin
JPS605567B2 (ja) オキシテトラサイクリンの調合液
PT91490B (pt) Processo para a preparacao de solucoes injectaveis contendo derivados de piridina
US4696814A (en) Parenteral phenytoin compositions
FI90824B (fi) Menetelmä kylmäkuivattujen farmaseuttisten fenyylikinoliinikarboksyylihappokoostumusten valmistamiseksi
RU2313346C2 (ru) Фармацевтическая композиция
JP2946015B2 (ja) 安定な抗ウィルス点滴用注射剤
KR100228752B1 (ko) 난용성 약물인 비페닐디메틸디카르복실레이트를 주성분으로 함유하는 액제 및 그 제조방법
RU1585944C (ru) Антибактериальное средство
US4088759A (en) Injectable pharmaceutical solutions
DK159957B (da) Fremgangsmaade til fremstilling af en til intravenoes indgivelse bestemt vandig oploesning af et sulfonamid sulfonamidpotentiator
KR100446098B1 (ko) 엔로플록사신주사제또는주입액제
US2755221A (en) Enhancing solubility of chlorethyltheophylline by nicotinamide and resulting composition

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19931123

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19931123